Home › Funds › Royce & Associates › ACA

Royce & Associates position in ACA

ARCOSA INC · Industrials

Royce & Associates reported holding 698,327 shares of ACA (ARCOSA INC) in its Q3 2026 13F filing — a position valued at US$102.1M, representing 0.93% of its reported portfolio and ranking #3 among its reported holdings. Royce & Associates has disclosed ACA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)698.33K sh
Reported value held$102.06M
Portfolio Weight0.93%
First reportedQ3 2021
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Royce & Associates's ACA position evolved

Royce & Associates first disclosed a stake in ACA in Q3 2021 at 1,628,149 shares (US$81.7M). The position peaked in Q2 2026 at 993,710 shares, worth US$144.4M. Across 21 filings, Royce & Associates increased the stake 7 time(s), trimmed it 11 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 698,327 shares valued at US$102.1M — a reduction of -295,383 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 1.63M $81.68M New
Q4 2021 1.80M $94.73M Add
Q1 2022 1.90M $108.67M Add
Q2 2022 1.95M $90.52M Add
Q3 2022 1.74M $99.25M Reduce
Q4 2022 1.53M $83.22K Reduce
Q1 2023 1.47M $92.96K Reduce
Q2 2023 1.42M $107.92M Reduce
Q3 2023 1.40M $100.88M Reduce
Q4 2023 1.46M $120.58M Add
Q1 2024 1.43M $122.55M Reduce
Q2 2024 1.43M $119.19M Hold
Q3 2024 1.37M $129.61M Reduce
Q4 2024 1.24M $119.88M Reduce
Q1 2025 1.25M $96.72M Add
Q2 2025 1.26M $109.47M Add
Q3 2025 1.27M $118.74M Hold
Q4 2025 1.23M $131.25M Reduce
Q1 2026 1.25M $132.92M Add
Q2 2026 993.71K $144.38M Reduce
Q3 2026 698.33K $102.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACA and 13F data

ACA (ARCOSA INC) is a Industrials company. 35 other funds we track also report a position in ACA — the largest reported positions include Pentwater Capital Management LP (US$306.9M), Balyasny Asset Management (US$172.4M), AQR Arbitrage LLC (US$108.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACA

All ACA fund holders →

FAQ

How long has Royce & Associates held ACA?

Royce & Associates has disclosed ACA holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Royce & Associates's current position in ACA?

As of Q3 2026, Royce & Associates holds 698.33K shares of ACA (ARCOSA INC), valued at $102.06M, representing 0.93% of its reported portfolio and ranking #3.

Has Royce & Associates been buying or selling ACA?

In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in ACA. The position peaked in Q2 2026 at 993.71K shares.

Which other funds hold ACA?

Other major institutional holders of ACA include Pentwater Capital Management LP, Balyasny Asset Management, AQR Arbitrage LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.